Related by context. All words. (Click for frequent words.) 69 Archexin 69 Ozarelix 68 registrational trial 68 forodesine 67 Phase 2b study 67 Phase Ib study 67 Amrubicin 67 alvespimycin 67 Bicifadine 67 GALNS 66 Phase 2a trial 66 Ophena TM 66 BEMA Buprenorphine 66 Mipomersen 66 teduglutide 66 Pimavanserin 66 HuMax EGFr 66 apaziquone 66 elotuzumab 66 pradefovir 65 PREOS 65 budesonide foam 65 eprotirome 65 luliconazole 65 Serdaxin 65 AEG# 65 Cetrorelix 65 TBC# 65 SUCCEED trial 65 phase IIb clinical 65 ruxolitinib 65 HuMax CD4 65 alvimopan 65 pharmacokinetic PK study 65 LibiGel ® 65 PF # [001] 65 ularitide 65 cannabinor 64 Aflibercept 64 ACAPODENE 64 Octreolin 64 eniluracil 64 selective androgen receptor modulator 64 Plicera 64 Ostarine 64 Elagolix 64 Capesaris 64 Acapodene 64 phase IIb 64 dirucotide 64 ThGRF 64 TH# [003] 64 bicifadine 64 JAK inhibitor 64 Phenoptin 64 IL# PE#QQR 64 voclosporin 64 HGS ETR1 64 Proxinium TM 64 PROMACTA 64 INCB# [002] 64 oral prodrug 64 oral deforolimus 64 EOquin TM 64 Phase III 64 YONDELIS 64 Panzem R NCD 64 ospemifene 64 Dapagliflozin 64 Phase IIb clinical trials 64 Traficet EN 64 trastuzumab DM1 64 PREOS R 64 RSD# oral 64 bardoxolone 64 cetrorelix 64 Pirfenidone 64 Silodosin 63 albinterferon alfa 2b 63 valopicitabine 63 AZILECT ® 63 Dextofisopam 63 Darusentan 63 PRT# 63 BEMA TM Fentanyl 63 AZILECT R 63 NEBIDO 63 Aurexis 63 Zingo TM 63 Phase IIb trials 63 oral ridaforolimus 63 Tamibarotene 63 PHX# 63 Phase Ib II 63 diabetic neuropathic pain 63 Dasatinib 63 metaglidasen 63 Urocidin 63 generation purine nucleoside 63 phase IIa 63 elagolix 63 palonosetron 63 phase IIa clinical 63 Tavocept 63 EOquin 63 eltrombopag 63 Phase 2b trial 63 topical NSAID 63 Phase 2a 63 Milnacipran 63 ThermoDox R 63 KRN# 63 Zerenex 63 terlipressin 63 EndoTAG TM -1 63 Azilect ® 63 Dacogen injection 63 ThermoDox ® 63 Phase IIb 63 Phase IIb trial 63 lurasidone 63 methylnaltrexone 63 Phase 2b 63 sulodexide 63 mapatumumab 63 Nuvion 63 ulimorelin 63 Phase III Clinical Trial 63 baminercept 63 EVIZON 63 OncoVEX GM CSF 62 Octreotide 62 BAL# [002] 62 TACI Ig 62 oral calcitonin 62 TELINTRA 62 ostarine 62 HuMax CD# 62 Phase #b/#a 62 Allovectin 7 ® 62 Canvaxin 62 methylnaltrexone bromide 62 INT# [002] 62 IPLEX 62 AeroLEF TM 62 phase IIb trial 62 LHRH antagonist 62 phase Ib 62 CCX# B 62 regorafenib 62 CBLC# 62 CTAP# Capsules 62 Gabapentin GR 62 Hsp# inhibitor 62 Golimumab 62 mertansine 62 dexanabinol 62 tezampanel 62 MEK inhibitor RDEA# 62 enzastaurin 62 Pivotal Phase III 62 Phase Ib 62 PXD# 62 FM VP4 62 Toremifene 62 ELACYT 62 NVA# 62 Increlex ® 62 subcutaneous formulation 62 Indaflex TM 62 Phase IIb clinical 62 R#/MEM # 62 prGCD 62 Targretin 62 cariprazine 62 ATL# [001] 62 Ambrisentan 62 torezolid phosphate 62 placebo controlled clinical 62 riociguat 62 lomitapide 62 OHR/AVR# 62 AEGR 62 SNT MC# 62 refractory gout 62 Pazopanib 62 Tasimelteon 62 Nexavar ® 62 Phase 1b 62 Phase IIa trial 62 velafermin 62 zanolimumab 62 Bezielle 62 Cinquil 62 BEMA Fentanyl 62 Azedra 62 RhuDex ® 62 Phase IIIb clinical 62 Triolex 62 epothilone 62 acyclovir Lauriad R 62 Vernakalant 62 aflibercept 62 Æterna Zentaris 62 amrubicin 62 maximally tolerated dose 62 AZX# 62 Hsp# Inhibitor 62 Elocalcitol 62 DU #b 62 Kepivance 62 PDE4 inhibitor 62 Ketotransdel 62 vandetanib 62 Afatinib 62 BRIM2 62 blinatumomab 62 satraplatin 62 MBP# [001] 62 IIa trial 62 axitinib 62 ruboxistaurin 62 INCB# [001] 62 Plenaxis TM 62 Amigal 62 UPLYSO 62 otelixizumab 61 GFT# 61 POSIDUR TM 61 sitaxsentan 61 Phase #/#a 61 Clevudine 61 ITAX 61 SEPET TM 61 glufosfamide 61 NGX# 61 Glufosfamide 61 RLY# 61 SinuNase 61 BCX# 61 Genz # 61 teriflunomide 61 BAY #-# 61 lubiprostone 61 goserelin 61 Kamada AAT 61 XL# [003] 61 Ixempra 61 pomalidomide 61 Fodosine 61 IRX 2 61 Phase IIB 61 incyclinide 61 NUVIGIL 61 Ventavis 61 Alpharadin 61 aclidinium 61 sorafenib tablets 61 CR# vcMMAE 61 Neurodex 61 Asentar 61 ACTEMRA TM 61 AP# [003] 61 Tocosol Paclitaxel 61 Alzhemed TM 61 reslizumab 61 pivotal Phase III 61 Chemophase 61 Desmoteplase 61 Phase 1b trial 61 EDEMA3 61 apremilast 61 Pemetrexed 61 FOLOTYN 61 Perifosine 61 CCX# 61 BLA filing 61 Tezampanel 61 Cloretazine ® 61 receptor tyrosine kinase inhibitor 61 Raptiva ® 61 randomized Phase IIb 61 DP b# 61 Vicinium TM 61 Androxal TM 61 Clinical Trial Results 61 ISENTRESS 61 Phase III clinical 61 pegylated interferons 61 Vicriviroc 61 perifosine 61 GSK# [001] 61 Orazol 61 GLYX 61 antiplatelet agent 61 Actemra tocilizumab 61 GAMMAGARD 61 ASA# 61 Torisel 61 deforolimus 61 ZOLINZA 61 rEV# 61 synthetic retinoid 61 Folotyn 61 octreotide implant 61 PSMA ADC 61 noninfectious uveitis 61 edoxaban 61 celgosivir 61 Aplidin 61 Debio 61 Rezular 61 rasagiline tablets 61 visilizumab 61 AeroLEF 61 LEVADEX ™ 61 Clolar ® 61 Zoraxel 61 dirucotide MBP# 61 Laquinimod 61 recurrent NSCLC 61 oxymorphone ER 61 AQ4N 61 evaluating tivozanib 61 Allovectin 7 61 ProSavin 61 IV Busulfex 60 iniparib 60 KNS # 60 Syncria 60 HGS# 60 tanespimycin 60 Zenvia Phase III 60 Loramyc R 60 Proquin XR 60 APTIVUS 60 SAR# [004] 60 RAPAFLO 60 Behcet uveitis 60 Phase 2a clinical 60 cangrelor 60 Aloxi R 60 cinacalcet HCl 60 PSN# [002] 60 Amplimexon 60 Pivotal Phase 60 ibandronate 60 Iloperidone 60 LCP AtorFen 60 Irinotecan 60 Zelrix 60 tocilizumab 60 Pivotal Trial 60 nalbuphine ER 60 MDV# 60 diarrhea predominant irritable 60 Tolvaptan 60 Lubiprostone 60 HRPC 60 EFAPROXYN 60 palifosfamide Zymafos TM 60 Nebido 60 huC# DM4 60 PRX# 60 tesetaxel 60 rilonacept 60 Phase III trials 60 Alocrest 60 Q#IR 60 urocortin 2 60 LymphoStat B TM 60 Initiate Phase 60 oral salmon calcitonin 60 CIMZIA TM 60 arzoxifene 60 TRV# [001] 60 Viramidine 60 VAPRISOL 60 LymphoStat B belimumab 60 Tarceva TM 60 Apaziquone 60 BrachySil TM 60 Relovair 60 lumiliximab 60 Degarelix 60 OMNARIS HFA 60 Icatibant 60 Annamycin 60 PEG SN# 60 pertuzumab 60 HspE7 60 Safinamide 60 lixisenatide 60 severe gastroparesis 60 custirsen 60 tesmilifene 60 Corlux 60 NP2 Enkephalin 60 SARMs 60 Pafuramidine 60 generation NNRTI 60 PEG PAL 60 TEMODAL 60 Allovectin 7 R 60 SUTENT 60 DPP4 inhibitor 60 ATL# [002] 60 CoFactor 60 anticancer compound 60 vascular disrupting agent 60 Vaprisol 60 Lu AA# 60 Phase IIa trials 60 Carfilzomib 60 Iluvien ® 60 VPRIV 60 Novolimus 60 Protexia R 60 MEK inhibitor 60 isavuconazole 60 hormone LHRH antagonist 60 luteinizing hormone releasing 60 PNP inhibitor 60 Ceflatonin 60 Restanza 60 Civacir 60 phase 2a 60 docetaxel Taxotere ® 60 Relivar 60 cethromycin 60 oral taxane 60 Personalized Immunotherapy 60 Reverset 60 Tracleer r 60 Surfaxin LS 60 XmAb# 60 cystinosis patients 60 denufosol 60 bendamustine HCl 60 ELADUR 60 PEGINTRON TM 60 Linaclotide 60 Avanafil 60 LE SN# 60 MYDICAR ® 60 Lodotra 60 TG# [003] 60 prostate cancer AIPC 60 Phase III Clinical Trials 60 Arcalyst 60 trospium 60 talactoferrin 60 Ophena 60 efficacy endpoint 60 tiapamil 60 Phase III Trial 60 Clonicel 60 INCB# [003] 60 Viprinex 60 Aclidinium 60 Microplasmin 60 belinostat 60 CLORETAZINE TM VNP#M 60 ONTAK 60 MIRCERA 60 Androxal 60 Daclizumab 60 vernakalant oral 60 dose escalation Phase 60 relapsed refractory multiple myeloma 60 PRX # 60 safinamide 60 corticosteroid dexamethasone 60 Luveniq 60 MEK inhibitors 60 biologic therapy 60 Xanafide 60 bardoxolone methyl 60 milnacipran 60 pulmonary arterial hypertension PAH 60 BYDUREON 60 PEG INTRON 60 ganetespib 60 confirmatory Phase III 60 Phase III HEAT 60 ZD# [001] 60 GLP toxicology studies 60 sorafenib Nexavar 60 vismodegib 60 Factor VIIa 60 ocrelizumab 60 AVE# 60 diclofenac sodium 60 mRCC 60 ORENCIA ® 60 linaclotide 60 GSK# [002] 60 dalbavancin 60 febuxostat 59 Reclast Aclasta 59 vemurafenib 59 CEQ# 59 docetaxel Taxotere R 59 orBec 59 ancrod 59 LidoPAIN SP 59 mGluR5 NAM 59 AzaSite Plus 59 multiple myeloma MM 59 STRIDE PD 59 Phase Ib clinical 59 Nimotuzumab 59 Aloxi injection 59 metastatic renal cell carcinoma 59 ZADAXIN 59 recurrent GBM 59 Androxal ® 59 Orapred ODT 59 IMA# 59 DDP# 59 efalizumab 59 motesanib 59 SILENOR 59 GATTEX 59 pharmacokinetic PK 59 LE DT 59 Phase IIB clinical 59 ADAGIO study 59 Fibrillex TM 59 Myocet 59 ZADAXIN ® 59 mipomersen 59 SinuNase TM 59 CIMZIA ™ 59 investigational humanized monoclonal antibody 59 Ocrelizumab 59 Phase 2b clinical 59 LY# [003] 59 ambrisentan 59 Exherin TM 59 Luteinizing Hormone Releasing Hormone 59 prostone 59 Zemplar Capsules 59 OPAXIO 59 Ofatumumab 59 Ereska 59 Lixivaptan 59 phase IIb study 59 Febuxostat 59 BENLYSTA 59 MAGE A3 ASCI 59 lupus nephritis 59 registrational 59 beta 1a 59 gallium containing 59 dosing cohort 59 GATTEX TM 59 Neovastat 59 Denosumab 59 biliary tract cancer 59 Cellegesic 59 CORT # 59 rALLy trial 59 SYMMETRY trial 59 darapladib 59 Azedra TM 59 Increlex R 59 OMNARIS Nasal Spray 59 BEMA TM LA 59 betrixaban 59 OMAPRO 59 dose cohort 59 Erbitux cetuximab 59 anidulafungin 59 administered subcutaneously 59 QVA# 59 Meets Primary Endpoint 59 Oglemilast 59 COPAXONE R 59 DR Cysteamine 59 dextofisopam 59 tasimelteon 59 talabostat 59 Genasense ® 59 Phase 2b Clinical Trial 59 anti TNF alpha 59 dextromethorphan quinidine 59 oral methylnaltrexone 59 opioid bowel dysfunction 59 Troxatyl 59 Flutiform TM 59 tipranavir 59 pegloticase 59 ORMD 59 Helsinn Healthcare 59 Nanobody 59 glucokinase activator 59 chronic angina 59 REMINYL ® 59 FOLOTYN ® 59 tramiprosate ALZHEMED TM 59 tramiprosate 59 Cimzia TM 59 LIVALO 59 neurogenic orthostatic hypotension 59 IIa clinical trial 59 plasma kallikrein inhibitor 59 6R BH4 59 ENTEREG ® 59 albiglutide 59 tolevamer 59 Itopride 59 abiraterone acetate 59 Viprinex TM 59 Nexavar sorafenib 59 ICA # 59 acute HAE attacks 59 Telbivudine 59 CDP# 59 huN# DM1 59 Argatroban 59 active comparator 59 metastatic hormone refractory 59 Insegia 59 Lupuzor 59 R# #mg BID 59 compound INCB# 59 relapsed ovarian cancer 59 lasofoxifene 59 initiate Phase 1b 59 Naproxcinod 59 Tyrima 59 TNF alpha inhibitor 59 Virulizin ® 59 oral formulation 59 Kissei Pharmaceutical 59 trastuzumab DM1 T DM1 59 XL# XL# XL# XL# 59 Palonosetron 59 LymphoStat B 59 ARIKACE 59 polymerase inhibitor 59 RANK Ligand inhibitor 59 tivozanib 59 Zavesca r 59 ATL/TV# 59 trastuzumab emtansine T DM1 59 refractory APL 59 canakinumab 59 Bremelanotide 59 Prodarsan 59 RSD# 59 Gefitinib 59 TASQ 59 Cleviprex TM clevidipine 59 tolvaptan 59 SUTENT ® 59 dose cohorts 59 romidepsin 59 GED aPC 59 Phase III Pivotal 59 refractory CLL 59 OvaRex ® MAb 59 Roche Xeloda 59 Solasia 59 maribavir 59 RhuDex 59 Interferon alpha 59 ACZ# 59 HER2 positive metastatic breast 59 drug ISA# 59 benign prostatic hypertrophy BPH 59 CUSTOM III 59 Darinaparsin 59 Candesartan 59 picoplatin 59 Loramyc 59 NUEDEXTA 59 Rescula 59 post menopausal osteoporosis 59 volociximab 59 DACH platinum 59 sapacitabine 59 tasocitinib 59 pexiganan 59 Virulizin R 59 fidaxomicin 59 pseudobulbar affect PBA 59 Onsolis 59 Firazyr 58 BZL# 58 Phase #b/#a clinical 58 Alvesco R 58 Phase Ib clinical trials 58 fipamezole 58 AGILECT R 58 IMGN# 58 Nasulin 58 HCV protease inhibitors 58 Puricase 58 IRESSA 58 fosbretabulin 58 Frova ® 58 cilengitide 58 Zoledronic acid 58 faropenem 58 R#/MEM 58 Diabetic Macular Edema 58 TREANDA 58 rFIXFc 58 velaglucerase alfa 58 ZACTIMA 58 TYZEKA 58 painful diabetic neuropathy 58 interferon gamma 1b 58 DEB# 58 prucalopride 58 Phase IIa clinical 58 Telatinib 58 vosaroxin 58 Tesetaxel 58 rilpivirine 58 PRTX 58 laquinimod 58 CYCLOSET 58 ALGRX 58 MGCD# [001] 58 AZOR 58 CINQUIL 58 interferon beta 1b 58 Anturol TM 58 Tekamlo 58 nitazoxanide 58 dasatinib Sprycel ® 58 XGEVA 58 MoxDuo TM IR 58 Apoptone 58 Bortezomib 58 Simulect 58 HGS ETR2 58 danoprevir 58 ELIQUIS 58 Ceflatonin R 58 LEUKINE 58 BENICAR HCT 58 nucleoside analog 58 CD3 monoclonal antibody 58 Menerba 58 Targretin capsules 58 daclizumab 58 Dalbavancin 58 Cethrin 58 GRN# 58 eculizumab 58 bosutinib 58 dexpramipexole 58 APPRAISE 58 PhosLo 58 Zybrestat 58 metastatic castration resistant 58 tamibarotene 58 oral rivaroxaban 58 LEP ETU 58 alfimeprase 58 clinical pharmacology studies 58 ENMD # 58 Frova R 58 OZURDEX ® 58 FASLODEX 58 RAPAFLO R 58 BRIM3 58 temsirolimus 58 brivaracetam 58 Preos 58 Advagraf 58 Phase III pivotal 58 Aurora kinase inhibitors 58 ThermoDox 58 MAP# 58 cediranib 58 Betaferon R 58 Metastatic Melanoma 58 PROSTVAC TM 58 SPRYCEL ® 58 MoxDuo 58 Preotact 58 Stedivaze 58 nimotuzumab 58 mitogen activated ERK kinase 58 Exelixis compounds 58 pain palliation 58 Dacogen decitabine 58 Sanctura XR 58 TMC# [002] 58 Rasagiline 58 CCR5 antagonist 58 APTIVUS r 58 CRMD# 58 investigational compound 58 Proellex TM 58 Satraplatin 58 preclinically 58 GVAX 58 ELND# 58 Amitiza 58 PRADAXA 58 virus HCV protease inhibitor 58 Kynapid 58 randomized controlled Phase 58 phase IIb III 58 dosage regimen 58 vidofludimus 58 CYT# potent vascular disrupting 58 bazedoxifene 58 Hycamtin 58 CYT# 58 post herpetic neuralgia PHN 58 recurrent glioblastoma 58 PLX cells 58 recurrent glioma 58 Locteron 58 PEGylated Fab fragment 58 LAS# [002] 58 atacicept 58 casopitant 58 adenosine injection 58 oncological indications 58 octreotide acetate 58 Pennsaid R 58 Zensana TM 58 ZYBRESTAT 58 nab paclitaxel 58 Diamyd ® 58 castration resistant prostate cancer 58 pediatric malignancies 58 cancer neuroendocrine tumor 58 Emezine 58 GW# [003] 58 DAVANAT 58 ISIS # 58 LibiGel Phase III 58 adecatumumab 58 SCH # 58 FUSILEV 58 ATPace 58 Combination REOLYSIN R 58 assessing T DM1 58 CCR9 antagonist 58 elinogrel 58 telbivudine 58 Phase III Trials 58 relapsed multiple myeloma 58 tolerability profiles 58 Dacogen 58 multi kinase inhibitor 58 Azixa 58 liposomal formulation 58 hormone refractory prostate cancer 58 Dual Opioid 58 TOCOSOL Camptothecin 58 USL# 58 proprietary transdermal patch 58 silodosin 58 LUX Lung 58 recombinant factor VIIa 58 Phase 2b clinical trials 58 ZALBIN dosed 58 bortezomib Velcade 58 indacaterol 58 briakinumab 58 Omacetaxine 58 miconazole Lauriad ® 58 Hedgehog antagonist 58 thymalfasin 58 Raptiva R 58 Onalta ™ 58 Panzem 58 Telaprevir 58 radezolid 58 Nilotinib 58 CytoFabTM 58 cell lymphoma CTCL 58 leading oral taxane 58 DXL# 58 orally bioavailable 58 Fx #A 58 bone metastases 58 Gattex 58 IV APAP 58 prostate cancer CRPC 58 dose escalation trial 58 EDEMA4 58 Fibrin Pad 58 Oxaliplatin 58 Phase 1b clinical 58 investigational monoclonal antibody 58 Toraymyxin TM 58 carcinoid syndrome 58 LB# [003] 58 cetrorelix pamoate 58 davunetide intranasal AL 58 BCR ABL inhibitor 58 topical ophthalmic 58 ZEGERID Capsules 58 Aurora kinase inhibitor 58 Quinamed 58 Arranon 58 CINTREDEKIN BESUDOTOX 58 ABSORB trial 58 Fabry Disease 58 TOLAMBA 58 CTA# Injection 58 rNAPc2 58 Cethrin R 58 HIV integrase inhibitor 58 OvaRex R 58 oral FTY# 58 renin inhibitor 58 overactive bladder syndrome 58 AKT inhibitor 58 postoperative ileus POI 58 TRO# 58 refractory angina 58 BENLYSTA ® 58 CIP TRAMADOL ER 58 Cethromycin 58 novel oral anticoagulant 58 metastatic HRPC 58 neratinib 58 afamelanotide 58 pharmacodynamic effects 58 Phase IIIb 58 DPX Survivac 58 inhaled AAT 58 PrevOnco ™ 58 posaconazole 58 Gemzar ® 58 decitabine 58 Serdolect ® 58 refractory prostate cancer 58 EP #R 58 Entereg R 58 systemic immunosuppressive drugs 58 vicriviroc 58 investigational antiplatelet agent 58 opioid induced bowel dysfunction 58 Vandetanib 58 injectable formulations 58 TG# [001] 58 metastatic CRC 58 Onco TCS 58 sJIA 58 Glypromate 58 avanafil 58 LIALDA 58 lintuzumab 58 Zenvia ™ 58 Phase 2b Trial 58 TRIOLEX 58 E2F Decoy 58 PROVENGE sipuleucel T 58 bendamustine 58 Ketotransdel ® 58 YONDELIS R 57 ixabepilone 57 Urocidin TM 57 Phase 1a clinical 57 MoxDuo IR 57 TRISENOX 57 Tarceva erlotinib 57 Randomized Phase 57 trabectedin 57 EDEMA3 trial 57 atrasentan 57 vorinostat 57 castrate resistant prostate cancer 57 IV NSCLC 57 lucinactant 57 vilazodone 57 octreotide 57 Aryplase 57 Cloretazine 57 Sapacitabine 57 LY# [002] 57 Chrysalin 57 Neuradiab 57 dacetuzumab 57 TORISEL 57 Benlysta belimumab 57 HCV RESPOND 2 57 generation Hsp# inhibitor 57 angiogenesis inhibitor 57 ANCHOR trial 57 mTOR inhibitor 57 Adentri 57 Gleevec imatinib mesylate 57 Crofelemer 57 docetaxel chemotherapy 57 CCR5 inhibitor